Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
12/2002
12/11/2002CN1384101A Bannamycin
12/11/2002CN1095837C Pyridazinone and application as fungicide
12/10/2002US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002US6492360 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/09/2002WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002US20020183326 1,2,4-triazolo[4,3-B]pyrido[3,2-D]pyridazine derivatives and pharmaceutical compositions containing them
12/05/2002US20020183325 Phthalazinone derivatives
12/05/2002CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/04/2002EP1261579A1 Dehydroamino acids
12/04/2002EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002CN1383425A Uracil substituted phenyl sulfamoyl carboxamides
12/03/2002US6489326 Sodium nucleinate, 2-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione sodium salt dihydrate, used as an immunomodulator, which also has antiinflammatory and antioxidant properties
11/2002
11/27/2002EP1260224A1 Sulfonyl pyridazinone compounds as therapeutic agents for ischemic tissue damage
11/26/2002US6486158 [4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia
11/26/2002CA2257142C 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
11/24/2002CA2387007A1 Therapies for tissue damage resulting from ischemia
11/21/2002WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002US20020173500 Hypotensive agents; antiischemic agents
11/21/2002CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/20/2002EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/19/2002US6482773 Pyridazin-3-one derivatives, their use, and intermediates for their production
11/14/2002WO2002090333A1 Novel pyridinone and related heterocyclic derivatives
11/12/2002US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002US6479494 Arylalkanoyl pyridazines
11/12/2002US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/07/2002WO2002087584A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002CA2445871A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/06/2002EP1254907A1 Pyrrolopyridazine compound
11/06/2002EP1030843A4 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
11/06/2002CN1093860C Pyridazino-[4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
11/05/2002US6476024 Pyridazine derivatives and related composition
11/05/2002US6475955 Pyridazinone derivatives
10/2002
10/31/2002WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002WO2002085885A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002CA2445236A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/30/2002EP1252146A1 Amide compounds for inhibiting protein kinases
10/29/2002US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002US6472391 Nitrogen-containing heterocyclic compounds
10/23/2002EP1000063B1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
10/23/2002CN1376153A Amide compounds
10/23/2002CN1376145A A meta-nitro phenol derivative and a process for producing it
10/23/2002CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/22/2002US6469003 Pyridazinone derivatives
10/17/2002WO2002080912A1 Reconstitutable parenteral composition containing a cox-2 inhibitor
10/16/2002EP1248620A1 A new use of levosimendan
10/16/2002EP1089737B1 Levosimendan for treating pulmonary hypertension
10/15/2002US6465647 Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
10/15/2002US6465646 1-alkoxy and 1-acyloxy substituted cyclohex-1-ene compounds and sulfur and 1-alkoxycarbonyl analogs having retinoid-like biological activity
10/15/2002US6465494 Methods for treatment of cystic fibrosis
10/15/2002US6465472 Substituted quinazolines and analogs and use thereof
10/15/2002US6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides
10/15/2002CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP0772590B1 Thrombin inhibitors
10/09/2002CN1092181C Benzyloxy substd, aromatics and their use as fungicides and insecticides
10/08/2002USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
10/08/2002US6462045 Method of treating pulmonary hypertension
10/08/2002US6462044 Therapy for sexual disorders
10/02/2002EP1245660A2 Liquid crystal compounds having bis(trifluoromethyl)phenyl rings, liquid crystal compositions and liquid crystal display devices
10/02/2002CN1372548A Heterocyclic compounds and medicinal use thereof
10/01/2002US6458788 4-hydroxycinnoline-3-carboxyamides as antiviral agents
09/2002
09/26/2002WO2002074267A1 Novel dyeing compositions for the dyeing of keratin fibres comprising 6-membered heterocyclic hydrazone compounds as an oxidation base
09/26/2002US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/25/2002EP1242424A2 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives
09/25/2002EP1242383A1 Aza compounds having neuronal activity
09/25/2002EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm
09/25/2002EP0931081B1 Pyridazino 4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
09/19/2002WO2002072099A1 Therapeutic and/or preventive agent for diabetic ischemic heart disease
09/19/2002US20020133007 Potato and corn crops
09/19/2002US20020133005 Heterocyclic compounds and medical use thereof
09/19/2002US20020132816 Estrogen agonists/antagonists for preventing breast cancer
09/19/2002US20020132794 Compounds and methods for inhibition of HIV and related viruses
09/19/2002DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use
09/17/2002CA2057338C Diarylfluoromethane compounds
09/12/2002WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/12/2002US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone
09/12/2002CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002CN1368956A Carbamate derivatives and agricultural/horticultural bactericides
09/11/2002CN1090612C Amine derivatives of oxo-and hydroxy-substituted hydrocarbons
09/10/2002US6448248 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
09/06/2002WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof
09/06/2002WO2002068367A1 A method to inhibit ethylene responses in plants
09/06/2002WO2002030405A3 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
09/06/2002WO2001090071A3 Substituted iminoazines used as herbicides
09/06/2002CA2438828A1 Aryl carbamate derivatives, preparation and use thereof
09/05/2002US20020123521 Such as triiodothyroacetic acid, triiodopropionic acid, 4-(2,6-dibromo-4-(1H-tetrazol-5-ylmethyl)-phenoxy)-2-isopropyl-phenol, and 4-(4-hydroxymethyl-2,6-diiodophenoxy)-2-iodo-phenol
09/05/2002US20020123496 Novel pyridazine derivatives and medicines containing the same as effective ingredients
09/05/2002DE10110325A1 Phenylderivate 2 Phenyl derivatives 2
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 85